m+Medelevator.RU
← Поиск публикаций
Enfermeria clinica · 2025

Infusion sets and vascular access as a strategy to address future challenges in intravenous therapy.

СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Rodríguez-Calero Miguel Ángel, Carr Peter J, Santos-Costa Paulo, Blanco-Mavillard Ian

Аннотация

This special article addresses a highly relevant issue in healthcare, where the demand for care and attention has significantly increased, coinciding with a progressively aging population and the prevalence of multiple chronic conditions. These factors pose considerable challenges for contemporary healthcare systems. Vascular access devices, including peripheral intravenous catheters, are widely utilized for intravenous therapy in hospitals; however, they are associated with risks and complications. Nearly 50% of these catheters are removed in an unplanned manner, which exacerbates the problem of catheter-associated bloodstream infections, leading to serious consequences such as increased mortality and higher hospital costs. Despite the interventions proposed by governmental organizations aimed at reducing these complications and enhancing healthcare quality, achieving this goal requires comprehensive knowledge and resources. This includes the use of various lancing devices and technologies, highlighting the imperative need for coordinated and collaborative actions by multidisciplinary teams. Moreover, the importance of professional specialization is crucial for transforming work dynamics into effective collaborative practices. In this context, Infusion and Vascular Access Devices (IVADs) have the potential to improve patient health, alleviate the discomfort associated with catheterization, and enhance patient satisfaction. They present a promising solution for optimizing the delivery of intravenous therapy and addressing future challenges in this field.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты